ACADIA PHARMACEUTICALS INC.
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $479.1M | $134.8M |
| FY2019 | — | $699.1M | $189.7M |
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |
Equity & Debt
| Fiscal Year | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| FY2018 | — | $479.1M | $134.8M |
| FY2019 | — | $699.1M | $189.7M |
| FY2020 | — | $627.0M | $326.0M |
| FY2021 | — | $540.9M | $147.4M |
| FY2022 | — | $400.4M | $114.8M |